TAKEDA CO. PLANNING TO SELL ITS OTC MEDICINE UNIT TO U.S BLACKSTONE GROUP INC.

Highlights –

• Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
• Takeda plans on selling the same for around $2.9 billion.
• Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.
• Blackstone Group has invested in real estate businesses and other companies in Japan.

Takeda Pharmaceutical Co. is currentl....